Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
Authors:
- A. Gomez-OutesAGA. Gomez-Outes
- A. I. Terleira-FernandezATA. I. Terleira-Fernandez
- M. L. Suarez-GeaMSM. L. Suarez-Gea
- E. Vargas-CastrillonEVE. Vargas-Castrillon
Open Access
Abstract
Read the full review for this F1000Prime recommended article: Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.Keywords
This publication has 42 references indexed in Scilit:
- Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacementInternational Orthopaedics, 2011
- Apixaban versus Enoxaparin for Thromboprophylaxis after Hip ReplacementNew England Journal of Medicine, 2010
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee ReplacementNew England Journal of Medicine, 2009
- Triggers, targets and treatments for thrombosisNature, 2008
- Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgeryJournal of Thrombosis and Haemostasis, 2007
- Frequency and timing of clinical venous thromboembolism after major joint surgeryThe Journal of Bone and Joint Surgery. British volume, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Incidence of symptomatic venous thromboembolism after different elective or urgent surgical proceduresThrombosis and Haemostasis, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986